DR. IVAN F. GONZALEZ-CANCEL, MD

SAN JUAN, PR

Research Active
Thoracic Surgery (Cardiothoracic Vascular Surgery) NPI registered 21+ years 3 publications 1995 – 2022 NPI: 1720084171
NeoplasmsLung NeoplasmsImmunosuppression TherapyHeart TransplantationActuarial Analysis

Practice Location

AVE AMERICO MIRANDA
SAN JUAN, PR 00927

Phone: (787) 281-0451

What does IVAN GONZALEZ-CANCEL research?

Dr. Gonzalez-Cancel studies a range of medical conditions primarily related to tumors and post-treatment complications. He has explored cases such as chylopericardium, a rare condition where fluid builds up around the heart, often following cancer treatments. His work emphasizes the importance of surgical interventions in diagnosing and treating tumors, as seen in his investigation into a giant solitary fibrous tumor, which was misidentified initially. His research underscores the need for careful monitoring of transplant patients for potential solid tumors, particularly following heart transplants, where the risk of cancer could significantly affect survival rates.

Key findings

  • In a case of recurrent chylopericardium, surgery was necessary after initial treatments were ineffective, demonstrating the complexities involved in managing this rare condition.
  • Digital clubbing was identified as an unusual first symptom of a giant solitary fibrous tumor, highlighting the importance of surgical diagnosis over biopsy in some cases.
  • Among heart transplant patients, 5.9% developed solid tumors, with lung cancer showing a 22% survival rate two years post-diagnosis, stressing the need for vigilant cancer surveillance after such procedures.

Frequently asked questions

Does Dr. Gonzalez-Cancel study chylopericardium?
Yes, he has researched recurrent chylopericardium, particularly in relation to patients with a history of cancer.
What types of tumors does Dr. Gonzalez-Cancel investigate?
He studies various tumors, including giant solitary fibrous tumors and solid tumors that can occur after heart transplantation.
Is Dr. Gonzalez-Cancel's work relevant to heart transplant patients?
Yes, his research emphasizes the need for monitoring solid tumors in heart transplant patients, as early detection can significantly affect outcomes.

Publications in plain English

Recurrent chylopericardium in a patient with history of left leg sarcoma.

2022

Journal of surgical case reports

Aboukheir-Aboukheir A, Lugo-Perez PM, Colon-Melendez E, Gonzalez-Cancel I, Boodoodingh-Casiano DR

Plain English
This study looks at a 43-year-old woman who developed a rare condition called chylopericardium, where fluid accumulates in the space around the heart after undergoing treatment for a type of cancer in her leg. After initial treatment didn't fully resolve her condition, she had surgery to remove the affected tissue and stop the fluid from returning. This matters because understanding how to effectively treat recurrent cases of chylopericardium can improve care for patients with similar health issues. Who this helps: This helps patients with recurrent chylopericardium and their doctors.

PubMed

Digital clubbing as first sign of giant solitary fibrous tumor. A case report.

2021

Journal of surgical case reports

Mejías-Lafontaine E, Galarza S, Gonzalez-Cancel I

Plain English
This study details the case of a 54-year-old woman who showed unusual swelling of her fingers (digital clubbing) as a first sign of a large tumor in her chest, known as a giant solitary fibrous tumor. Initially thought to be benign based on a biopsy, the tumor was later found to be malignant after it was completely removed. This highlights the importance of surgery for diagnosis and treatment, rather than relying solely on biopsy results. Who this helps: This information benefits doctors and patients by emphasizing the need for thorough treatment in cases of suspected solitary fibrous tumors.

PubMed

Solid tumors after heart transplantation: lethality of lung cancer.

1995

The Annals of thoracic surgery

Pham SM, Kormos RL, Landreneau RJ, Kawai A, Gonzalez-Cancel I +3 more

Plain English
This study looked at the occurrence of solid tumors, particularly lung cancer, in patients who had heart transplants. It found that 5.9% of transplant recipients developed solid tumors, with skin tumors being the most common followed by lung cancer, which had a very low two-year survival rate of only 22%. The results highlight the importance of monitoring for tumors after heart transplantation, as early detection could improve outcomes, especially given that many lung cancer cases were diagnosed at an advanced stage. Who this helps: This research benefits heart transplant patients and their doctors by emphasizing the need for regular cancer screenings post-surgery.

PubMed

Frequent Co-Authors

Aihab Aboukheir-Aboukheir Paloma M Lugo-Perez Eduardo Colon-Melendez Dev R Boodoodingh-Casiano Emanuel Mejías-Lafontaine Sandra Galarza S M Pham R L Kormos R J Landreneau A Kawai

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.